Nintedanib Impurity 95 | CAS 2102162-79-6 - Request Quote
Nintedanib Impurity 95
| SZ CAT No: | SZ-N023132 |
| CAS No | 2102162-79-6 |
| Mol.F. | C22H22N2O3 |
| Mol.Wt. | 362.4 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Nintedanib Impurity 95 is chemically Methyl (Z)-2-oxo-3-(phenyl(piperidin-1-yl)methylene)indoline-6-carboxylate. Nintedanib Impurity 95 is supplied with detailed characterization data compliant with regulatory guideline. Nintedanib Impurity 95 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Nintedanib.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 2102162-79-6
Purchase 2102162-79-6
Order 2102162-79-6
Enquire 2102162-79-6
price of 2102162-79-6
2102162-79-6 Supplier
2102162-79-6 Manufacturer
2102162-79-6 Exporter
buy high quality Nintedanib Impurity 95
Purchase Nintedanib Impurity 95
Nintedanib Impurity 95 suppliers
Nintedanib Impurity 95 manufacturers
Nintedanib Impurity 95 price
Order Nintedanib Impurity 95
Enquire Nintedanib Impurity 95
Nintedanib Impurity 95 cost
Nintedanib Impurity 95 Supplier
Nintedanib Impurity 95 Distributor
Nintedanib Impurity 95 for Method Validation
Nintedanib Reference Standard
Nintedanib Impurity 95 for ANDA Filing
Nintedanib Impurity 95 for Forced Degradation Studies
Nintedanib Impurity 95 Identification Standards
Nintedanib Impurity 95 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.